TransAlta Stock Fund Trims: What It Signals for Investors
A major fund reduced its TransAlta stake in Q4, sparking questions about the stock’s trajectory. This article explain...
Knowing when to rebalance keeps your retirement plan on track. This intro covers indicators and a simple action plan.
17,694 articlesA major fund reduced its TransAlta stake in Q4, sparking questions about the stock’s trajectory. This article explain...
When an asset manager sells million shares of a popular bond ETF, it can signal shifts in liquidity and portfolio str...
Insider moves often raise questions for investors. This piece breaks down what Arteris CEO's stock sale could mean, h...
When a major tariff ruling shifts import costs, retail stocks can respond quickly. This article breaks down why these...
Biotech stocks often ride a volatile wave of news, milestones, and insider moves. In the last year, one biotechnology...
Two Invesco health care ETFs offer different paths to play the GLP-1 revolution. This guide breaks down how invesco's...
When a major IEEPA tariff ruling shifts policy, winners emerge in unexpected places, but the losers often reveal the ...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Two heavyweight tech stocks have surged on AI bets, but investors face a stark choice: own NVIDIA stock or Micron sto...
A day of mixed signals, with Nvidia’s surge fading and tech shares pulling the Nasdaq and S&P 500 lower. Here’s what ...
On a day shaped by geopolitical optimism, the stock market today showed modest gains as investors priced in the poten...
Choosing between XLF and FNCL can feel like balancing risk and reward in the financial sector. This guide breaks down...